61 related articles for article (PubMed ID: 32453443)
1. Patterns of metastases of prostatic ductal adenocarcinoma.
Ranasinghe WKB; Brooks NA; Elsheshtawi MA; Davis JW; Bathala TK; Tang C; Troncoso P; Aparicio A; Tu SM; Pisters LL; Chapin BF
Cancer; 2020 Aug; 126(16):3667-3673. PubMed ID: 32453443
[TBL] [Abstract][Full Text] [Related]
2. Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management.
Ranasinha N; Omer A; Philippou Y; Harriss E; Davies L; Chow K; Chetta PM; Erickson A; Rajakumar T; Mills IG; Bryant RJ; Hamdy FC; Murphy DG; Loda M; Hovens CM; Corcoran NM; Verrill C; Lamb AD
BJUI Compass; 2021 Jan; 2(1):13-23. PubMed ID: 35474657
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of neuroendocrine prostate cancer.
Conteduca V; Oromendia C; Eng KW; Bareja R; Sigouros M; Molina A; Faltas BM; Sboner A; Mosquera JM; Elemento O; Nanus DM; Tagawa ST; Ballman KV; Beltran H
Eur J Cancer; 2019 Nov; 121():7-18. PubMed ID: 31525487
[TBL] [Abstract][Full Text] [Related]
4. Defining Diagnostic Criteria for Prostatic Ductal Adenocarcinoma at Multiparametric MRI.
Ranasinghe WKB; Troncoso P; Surasi DS; Ibarra Rovira JJ; Bhosale P; Szklaruk J; Kokorovic A; Wang X; Elsheshtawi M; Zhang M; Aparicio A; Chapin BF; Bathala TK
Radiology; 2022 Apr; 303(1):110-118. PubMed ID: 35076303
[TBL] [Abstract][Full Text] [Related]
5. Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.
Marra G; van Leenders GJLH; Zattoni F; Kesch C; Rajwa P; Cornford P; van der Kwast T; van den Bergh RCN; Briers E; Van den Broeck T; De Meerleer G; De Santis M; Eberli D; Farolfi A; Gillessen S; Grivas N; Grummet JP; Henry AM; Lardas M; Lieuw M; Linares Espinós E; Mason MD; O'Hanlon S; van Oort IM; Oprea-Lager DE; Ploussard G; Rouvière O; Schoots IG; Stranne J; Tilki D; Wiegel T; Willemse PM; Mottet N; Gandaglia G;
Eur Urol; 2023 Jul; 84(1):65-85. PubMed ID: 37117107
[TBL] [Abstract][Full Text] [Related]
6. Associations between Body Mass Index and Prostate Cancer: The Impact on Progression-Free Survival.
Popovici D; Stanisav C; Pricop M; Dragomir R; Saftescu S; Ciurescu D
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837490
[No Abstract] [Full Text] [Related]
7. Radiotherapy for ductal carcinoma of the prostate: an analysis based on the Japanese radiation oncology study group survey.
Kawamura H; Nakamura K; Yoshioka Y; Itasaka S; Tomita N; Onishi M; Iwata H; Aizawa T; Kikuchi K; Nagata K; Nakamura K; Nishioka K; Ishiyama H; Ueno S; Kokubo M; Yamazaki H; Watanabe K; Toyoda T; Akimoto T;
Jpn J Clin Oncol; 2023 Jan; 53(2):146-152. PubMed ID: 36478251
[TBL] [Abstract][Full Text] [Related]
8. Presenting stage and risk group in men dying of prostate cancer.
Parimi S; Bondy S; Aparicio M; Sunderland K; Cho J; Bachand F; Nguyen Chi K; Pickles T; Tyldesley S
Curr Oncol; 2020 Dec; 27(6):e547-e551. PubMed ID: 33380869
[TBL] [Abstract][Full Text] [Related]
9. Lifetime Follow-Up of a Patient with Metastatic Prostate Cancer Undergoing Multiple Surgical Resections: A Case Report.
Nanashima A; Nagayasu T; Yamasaki N; Tsuchiya T; Matsumoto K; Tagawa T; Arai J
Am J Case Rep; 2023 Nov; 24():e941668. PubMed ID: 37939016
[TBL] [Abstract][Full Text] [Related]
10. Estimating the Number of Men Living with Metastatic Prostate Cancer in the United States.
Devasia TP; Mariotto AB; Nyame YA; Etzioni R
Cancer Epidemiol Biomarkers Prev; 2023 May; 32(5):659-665. PubMed ID: 36716178
[TBL] [Abstract][Full Text] [Related]
11. Ductal adenocarcinoma of the prostate with oncocytic morphology.
Punjabi LS; Ng CK; Cheng L; Tan PH
Pathology; 2024 Apr; 56(3):415-419. PubMed ID: 37739923
[No Abstract] [Full Text] [Related]
12. Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study.
Eule CJ; Hu J; Al-Saad S; Collier K; Boland P; Lewis AR; McKay RR; Narayan V; Bosse D; Mortazavi A; Rose TL; Costello BA; Bryce AH; Lam ET
Clin Genitourin Cancer; 2023 Aug; 21(4):483-490. PubMed ID: 37193610
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Differences Between Prostate Cancer Patients Presenting With De Novo Versus Primary Progressive Metastatic Disease.
Finianos A; Gupta K; Clark B; Simmens SJ; Aragon-Ching JB
Clin Genitourin Cancer; 2017 Aug; ():. PubMed ID: 28899723
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy with curative intention in men with
Montero A; Hernando O; Cañon V; Guevara D; Valero J; Chen-Zhao X; Garcia-Acilu P; Sanchez E; Lopez M; Ciervide R; Garcia-Aranda M; Alvarez B; Prado A; Alonso R; Fernandez-Leton P; Rubio C
Rep Pract Oncol Radiother; 2021; 26(4):605-615. PubMed ID: 34434577
[TBL] [Abstract][Full Text] [Related]
15. Rectal Tropism: An Extremely Rare Case of Prostate Cancer Recurrence With Metastasis to the Rectum Postradical Prostatectomy.
Trivedi A; Bathobakae L; Shenasan P; Yuridullah R; Akmal A; El-Sedfy A
J Investig Med High Impact Case Rep; 2023; 11():23247096231211053. PubMed ID: 37942542
[TBL] [Abstract][Full Text] [Related]
16. Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping.
Warner EW; Van der Eecken K; Murtha AJ; Kwan EM; Herberts C; Sipola J; Ng SWS; Chen XE; Fonseca NM; Ritch E; Schönlau E; Bernales CQ; Donnellan G; Munzur AD; Parekh K; Beja K; Wong A; Verbeke S; Lumen N; Van Dorpe J; De Laere B; Annala M; Vandekerkhove G; Ost P; Wyatt AW
Nat Cancer; 2024 Jan; 5(1):114-130. PubMed ID: 38177459
[TBL] [Abstract][Full Text] [Related]
17. Prostate gland metastasis as a late relapse of rectal adenocarcinoma.
Hernández Alonso R; Soto Sánchez A; Lara Castro A; Hernández Barroso M; Pérez Sánchez E; Díaz Jiménez N; Hernández Hernández G; Barrera Gómez MÁ
Rev Esp Enferm Dig; 2023 Feb; 115(2):97-98. PubMed ID: 35748476
[TBL] [Abstract][Full Text] [Related]
18. [Clinically rare subtypes of prostate cancer: Progress in research].
Sheng ZC; Dong J; Xu S
Zhonghua Nan Ke Xue; 2023 Mar; 29(3):264-268. PubMed ID: 38597709
[TBL] [Abstract][Full Text] [Related]
19. First case of ductal adenocarcinoma of the prostate with MAP3K1 homozygous deletion.
Shojo K; Kosaka T; Nakamura K; Hongo H; Kobayashi H; Mikami S; Nishihara H; Oya M
IJU Case Rep; 2021 May; 4(3):176-179. PubMed ID: 33977253
[TBL] [Abstract][Full Text] [Related]
20.
Fukagawa E; Yuasa T; Inamura K; Hamada K; Fujiwara M; Komai Y; Yonese J
IJU Case Rep; 2022 Nov; 5(6):505-510. PubMed ID: 36341182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
